ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
Dow Jones
43.297,03
0,91%
Euro vs US Dollar
1,04007
0,02%
Bitcoin
95.426,36
-3,89%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV

  6. Medexus Pharmaceuticals Inc (MDP) Börsenkurse

Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc (MDP)

Medexus Pharmaceuticals Inc
7,75
0,00
(0,00%)
Geschlossen 26 Dezember 10:00PM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
7,75
Gebot
7,80
Fragen
7,85
Volumen
-
0,00 Tagesbereich 0,00
7,75 52-Wochen-Bereich 7,75
Marktkapitalisierung
189,55M
Handelsende
7,75
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
24.458.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-373,56
Gewinn pro Aktie (EPS)
-0,01
Erlöse
113,05M
Nettogewinn
-214k

Über Medexus Pharmaceuticals Inc

Sektor
Pharmaceutical Preparations
Branche
Blank Checks
Website
www.medexus.com
Hauptsitz
Bolton, Gbr
Gegründet
2013
Medexus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker MDP. The last closing price for Medexus Pharmaceuticals was $7,75. Over the last year, Medexus Pharmaceuticals shares have traded in a share price range of $ 7,75 to $ 7,75.

Medexus Pharmaceuticals currently has 24.458.000 shares in issue. The market capitalisation of Medexus Pharmaceuticals is $189,55 million. Medexus Pharmaceuticals has a price to earnings ratio (PE ratio) of -373.56.

MDP Neueste Nachrichten

Weitere Nachrichten

Complete Response Letter Received from FDA for Treosulfan

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced...

03 August 2021
GlobeNewswire Inc.

Medexus Appoints New Chief Financial Officer

TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad...

19 Juli 2021
GlobeNewswire Inc.

Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in C...

TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered...

12 Juli 2021
GlobeNewswire Inc.

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of...

28 Juni 2021
GlobeNewswire Inc.

Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash equivalents of $18.7 million and available liquidity of $24.8 million at March 31, 2021...

16 Juni 2021
GlobeNewswire Inc.

Medexus Announces Graduation to the Toronto Stock Exchange

TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final...

15 Juni 2021
GlobeNewswire Inc.

Medexus to Present at Raymond James Human Health Innovation Conference

TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

14 Juni 2021
GlobeNewswire Inc.

Medexus Schedules Fiscal Year 2021 Conference Call

TORONTO and CHICAGO and MONTREAL, June 11, 2021 (GLOBE NEWSWIRE) -- , June 11, 2021 - Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today...

11 Juni 2021
GlobeNewswire Inc.

Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

TORONTO, CHICAGO and MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it...

10 Juni 2021
GlobeNewswire Inc.

Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

09 Juni 2021
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1007.757.757.7500CS
4007.757.757.7500CS
12007.757.757.7500CS
26007.757.757.7500CS
52007.757.757.7500CS
156007.757.757.7500CS
2603.93102.8795811523.829.751.4280696.80406428CS

MDP - Frequently Asked Questions (FAQ)

What is the current Medexus Pharmaceuticals share price?
The current share price of Medexus Pharmaceuticals is $ 7,75
How many Medexus Pharmaceuticals shares are in issue?
Medexus Pharmaceuticals has 24.458.000 shares in issue
What is the market cap of Medexus Pharmaceuticals?
The market capitalisation of Medexus Pharmaceuticals is CAD 189,55M
What is the 1 year trading range for Medexus Pharmaceuticals share price?
Medexus Pharmaceuticals has traded in the range of $ 7,75 to $ 7,75 during the past year
What is the PE ratio of Medexus Pharmaceuticals?
The price to earnings ratio of Medexus Pharmaceuticals is -373,56
What is the cash to sales ratio of Medexus Pharmaceuticals?
The cash to sales ratio of Medexus Pharmaceuticals is 0,7
What is the reporting currency for Medexus Pharmaceuticals?
Medexus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Medexus Pharmaceuticals?
The latest annual turnover of Medexus Pharmaceuticals is USD 113,05M
What is the latest annual profit for Medexus Pharmaceuticals?
The latest annual profit of Medexus Pharmaceuticals is USD -214k
What is the registered address of Medexus Pharmaceuticals?
The registered address for Medexus Pharmaceuticals is 35 NIXON ROAD, UNIT 1, BOLTON, L7E 1K1
What is the Medexus Pharmaceuticals website address?
The website address for Medexus Pharmaceuticals is www.medexus.com
Which industry sector does Medexus Pharmaceuticals operate in?
Medexus Pharmaceuticals operates in the BLANK CHECKS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,04
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,30
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,04
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,30
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,04
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,30
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSXV
MDP
Medexus Pharmaceuticals
TSXV
AXM.H
AXMIN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten